Vimarsana
Biggest News Aggregation in the World

Page 37 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

Former superintendent of Cincinnati Technology Academy sentenced - Vimarsana News

Former superintendent of Cincinnati Technology Academy sentenced

The former superintendent of a Cincinnati charter school was fined $1,000 and ordered to complete 100 hours of community service after a janitorial business he controlled was improperly contracted to provide services to the school, Auditor of State Keith Faber announced.

InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares - Vimarsana News

InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares

JENA, Germany, April 14, 2023 -- InflaRx N.V. , a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today that it has... | April 14, 2023

EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023 - Vimarsana News

EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023

EQS-News: Heidelberg Pharma AG / Key word(s): Interim Report Heidelberg Pharma AG: Interim Management Statement on the First Three Mo...

EQS-News: Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® - Vimarsana News

EQS-News: Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer

InflaRx Announces Pricing of $40 Million Public Offering of - Vimarsana News

InflaRx Announces Pricing of $40 Million Public Offering of

JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing...